You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK)擬根據特別授權配售6820.54萬股 融資約73.7億港元
格隆匯 07-29 06:17

格隆匯7月29日丨藥明康德(02359.HK)發佈公告,2020年7月29日(交易時間前),公司與Morgan Stanley & Co. International Plc、華泰金融控股(香港)有限公司、高盛(亞洲)有限責任公司及 J.P. Morgan Securities Plc(統稱“配售代理”)訂立配售協議,據此,公司同意委任配售代理而配售代理各自同意(而非共同,亦非共同及個別)出任公司代理,並盡力促使若干承配人按照配售協議所載條款及條件,按每股配售股份108.0港元合共認購公司根據特別授權將發行的6820.54萬股新H股。

配售股份數目分別佔截至該公告日期現有已發行H股總數及現有已發行股份總數約28.57%及2.95%;及緊隨完成後經發行配售股份擴大後的已發行H股總數及已發行股份總數約22.22%及2.87%。配售價每股配售股份108.0港元較7月28日收市價每股H股113.90港元折讓約5.2%。

假設所有配售股份獲悉數認購,配售所得款項總額預期將約為73.7億港元。配售的募集資金淨額預計約為72.9億港元(按每股配售股份淨價約106.95港元計算)。其中,約35.0%用於併購,包括但不限於擴展集團於美國、歐洲及亞太區的業務;約20.0%用於擴展集團海外業務;約15.0%用於建設常熟研發一體化項目;約10.0%用於償還銀行貸款及其他借款;及剩餘金額用於補充公司的營運資金。

配售股份預期將配售予不少於六名獨立承配人(須為專業、機構及其他投資者)。配售股份將根據特別授權發行。配售毋須股東另行批准。公司將向香港聯交所上市委員會申請批准配售股份上市及買賣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account